Fundraising FoxChattanooga Renaissance Fund — 2014 Investments
2 investments dated 2014 · listed companies and verified rows first · show all
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation.
BiotechHealthtechMedical Devices
Paul J. Fitzpatrick(Chief Executive Officer)
PartnerDavid Belitz· solo GP
Co-investorsInnova Memphis, Inc.Solas BioVenturesBlank Slate Ventures
Chattanooga, US
Alexis Tarumianz(Executive Officer, Director)Jennifer Store(Executive Officer, Director)in
PartnerDavid Belitz· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.